1. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield
   Juanjuan Ou et al, 2019, Nature Communications CrossRef
2. Evaluation of combined use of hsp90 inhibitor mpc-3100 and traditional cancer drug 5-fu on liver cancer cell lines
   Özlem KAPLAN, 2023, Journal of Scientific Reports-A CrossRef
3. Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis
   Vincent Chin-Hung Chen et al, 2023, International Journal of Molecular Sciences CrossRef
4. Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review
   Suqi Zhu et al, 2024, Expert Review of Anticancer Therapy CrossRef
5. The combination of curcumin and 5-fluorouracil in cancer therapy
   Yumeng Wei et al, 2018, Archives of Pharmacal Research CrossRef
6. The reversible reproductive toxicity of 5-fluorouracil in mice
   Gerile Naren et al, 2021, Reproductive Toxicology CrossRef
7. Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint
   Kai Zheng et al, 2016, Autophagy CrossRef
8. Combination treatment with sorafenib and wh‑4 additively suppresses the proliferation of liver cancer cells
   Su-Hong Chen et al, 2022, Experimental and Therapeutic Medicine CrossRef
9. Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures
   Simonas Daunys et al, 2019, Scientific Reports CrossRef